Brazil's Butantan Institute identified a new mite larvae, Araneothrombium brasiliensis, feeding on a spider in a museum ...

A single-dose dengue vaccine produced by Butantan Institute in São Paulo state (Brazil) prevents development of the disease in 79.6% of those vaccinated, according to an article published today ...

Under the agreement, Instituto Butantan will conduct registrational clinical trials of Replicate's novel srRNA rabies vaccine for post-exposure and pre-exposure prophylaxis Replicate to provide GMP ...

BRASÍLIA (Reuters) - Brazilians should prepare for annual COVID-19 immunizations to reinforce vaccines currently available, the head of public-sector laboratory Butantan said on Thursday. Annual ...

A single dose of just 0.5 milliliters (mL) of the candidate vaccine against dengue from the Butantan Institute, Butantan DV, provided lasting and elevated protection against the disease. It reduced ...

BRASILIA/RIO - Jan 28 (Reuters) - Sao Paulo’s state Butantan biomedical center in Brazil has capacity to produce 40 million extra doses of the vaccine developed by China’s Sinovac Biotech, which could ...

Lyon (France), Sao Paulo, (Brazil), February 3, 2026 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company and Instituto Butantan, one of the world’s largest biomedical research ...

Saint-Herblain (France), Sao Paulo, (Brazil), January 25, 2021 – ValnevaSE (“Valneva” or “the Company”), a specialty vaccine company focused on prevention of infectious diseases with significant unmet ...

On Wednesday, December 12, 2018, Brazil's Butantan Institute signed a collaboration agreement with Merck Sharp & Dohme (MSD) to develop dengue vaccines. The São Paulo State research institution and ...

Brazilians should prepare for annual COVID-19 immunizations to reinforce vaccines currently available, the head of public-sector laboratory Butantan said on Thursday. BRASÍLIA, May 27 (Reuters) - ...